The unique composition of the intimate flora evabiote combines rhamnosus species and acidophilus species, representing 5 billion CFU (colony-forming units) per capsule. These two species have the advantage of resisting stomach acidity and the migration of digestive tracts to the vagina. They complement each other in inhibiting the growth of pathogenic flora. The flora's effectiveness intima of evabiote has been clinically demonstrated in several studies, following pharmacological treatment, particularly in cases of recurrent vaginal yeast infection or recurrent bacterial vaginosis.
